Fulcrum Therapeutics Inc.
FULC | NASDAQ
$3.80
+$0.04 (+1.06%)
At close: Sep 21, 2026, 4:00 PM ET
$3.80
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:56 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | 80M | 2.81M | 6.34M | 19.16M | 8.82M |
Cost of Revenue | 1.39M | 63.39M | 71.8M | 76.78M | 69.7M | 59.04M |
Gross Profit | -1.39M | 16.61M | -69M | -70.44M | -50.54M | -50.22M |
Operating Income | -84.77M | -21.9M | -110.66M | -112.56M | -81.05M | -71.61M |
Interest Income | n/a | n/a | n/a | n/a | 207K | 792K |
Pretax Income | -74.88M | -9.73M | -97.34M | -109.87M | -80.85M | -70.82M |
Net Income | -74.88M | -9.73M | -97.34M | -109.87M | -80.85M | -70.82M |
Selling & General & Admin | 28.67M | 36.45M | 41.67M | 41.69M | 30.52M | 21.39M |
Research & Development | 56.1M | 63.39M | 71.8M | 76.78M | 69.7M | 59.04M |
Other Expenses | -1.39M | -61.32M | -71.8M | -76.36M | -69.7M | -59.04M |
Operating Expenses | 83.38M | 38.51M | 41.67M | 42.12M | 30.52M | 21.39M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 1.48M | 2.52M | n/a | n/a | n/a |
Cost & Expenses | 84.77M | 101.9M | 113.47M | 118.9M | 100.22M | 80.43M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 63.36M | 61.98M | 61.31M | 44.99M | 35.36M | 25.35M |
Shares Outstanding (Diluted) | 63.36M | 61.98M | 61.31M | 44.99M | 35.36M | 25.35M |
EPS (Basic) | -1.18 | -0.16 | -1.59 | -2.35 | -2.22 | -2.70 |
EPS (Diluted) | -1.18 | -0.16 | -1.59 | -2.35 | -2.22 | -2.70 |
EBITDA | -73.49M | -18.24M | -95.16M | -109.72M | -78.33M | -69.23M |
EBIT | -74.88M | -19.83M | -97.34M | -112.13M | -80.85M | -71.61M |
Depreciation & Amortization | 1.39M | 1.59M | 2.17M | 2.41M | 2.52M | 2.38M |
Add to Watchlist
Select watchlists to add or remove FULC